Phase I/II Clinical Study of GT201 Injection as Monotherapy or in Combination With PD-1 Inhibitor for Advanced Solid Tumors
Clinical trial NCT06144671 · RECRUITING
Trial details
- NCT number
- NCT06144671
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-12-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.